Combined Heart Lung Transplantation: An Updated Review of the Current Literature

被引:18
作者
Pasupneti, Shravani [1 ]
Dhillon, Gundeep [1 ]
Reitz, Bruce [3 ]
Khush, Kiran [2 ]
机构
[1] Stanford Univ, Sch Med, Dept Pulm & Crit Care, 300 Pasteur Dr,Rm H3143,MC 5236, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Cardiothorac Surg, 300 Pasteur Dr,Rm H3143,MC 5236, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Cardiovasc Med, 300 Pasteur Dr,Rm H3143,MC 5236, Stanford, CA 94305 USA
关键词
ANTI-THYMOCYTE GLOBULIN; BRONCHIOLITIS OBLITERANS SYNDROME; EARLY GRAFT FAILURE; INTERNATIONAL SOCIETY; ALLOGRAFT VASCULOPATHY; PULMONARY-HYPERTENSION; CELLULAR REJECTION; ADULT LUNG; RECIPIENTS; INDUCTION;
D O I
10.1097/TP.0000000000001820
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Heart lung transplantation is a viable treatment option for patients with many end-stage heart and lung pathologies. However, given the complex nature of the procedure, it is imperative that patients are selected appropriately, and the clinician is aware of the many unique aspects in management of this population. This review seeks to describe updated organ selection policies, perioperative and postoperative management strategies, monitoring of graft function, and clinical outcomes for patients after combined heart-lung transplantation in the current era.
引用
收藏
页码:2297 / 2302
页数:6
相关论文
共 31 条
[1]   Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab [J].
Ansari, David ;
Lund, Lars H. ;
Stehlik, Josef ;
Andersson, Bodil ;
Hoeglund, Peter ;
Edwards, Leah ;
Nilsson, Johan .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (10) :1283-1291
[2]   Induction therapy in lung transplantation: A prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab [J].
Brock, MV ;
Borja, MC ;
Ferber, L ;
Orens, JB ;
Anzcek, RA ;
Krishnan, J ;
Yang, SC ;
Conte, JV .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (12) :1282-1290
[3]   The incidence of acute cellular rejection after lung transplantation: A comparative study of anti-thymocyte globulin and daclizumab [J].
Burton, CM ;
Andersen, CB ;
Jensen, AS ;
Iversen, M ;
Milman, N ;
Boesgaard, S ;
Arendrup, H ;
Eliasen, K ;
Carlsen, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (06) :638-647
[4]  
CHAPELIER A, 1993, J THORAC CARDIOV SUR, V106, P299
[5]   The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report-2012 [J].
Christie, Jason D. ;
Edwards, Leah B. ;
Kucheryavaya, Anna Y. ;
Benden, Christian ;
Dipchand, Anne I. ;
Dobbels, Fabienne ;
Kirk, Richard ;
Rahmel, Axel O. ;
Stehlik, Josef ;
Hertz, Marshall I. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (10) :1073-1086
[6]  
Eurotransplant, EUR MAN
[7]   Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients [J].
Fadel, Elie ;
Mercier, Olaf ;
Mussot, Sacha ;
Leroy-Ladurie, Francois ;
Cerrina, Jacques ;
Chapelier, Alain ;
Simonneau, Gerald ;
Dartevelle, Philippe .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 38 (03) :277-284
[8]   Phrenic nerve dysfunction after heart-lung and lung transplantation [J].
Ferdinande, P ;
Bruyninckx, F ;
Van Raemdonck, D ;
Daenen, W ;
Verleden, G .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (01) :105-109
[9]   The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients [J].
Furuya, Y. ;
Jayarajan, S. N. ;
Taghavi, S. ;
Cordova, F. C. ;
Patel, N. ;
Shiose, A. ;
Leotta, E. ;
Criner, G. J. ;
Guy, T. S. ;
Wheatley, G. H. ;
Kaiser, L. R. ;
Toyoda, Y. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) :2334-2341
[10]  
Gray H., 1918, ANATOMY HUMAN BODY